LifeLink Ventures

LifeLink Ventures is a venture capital firm dedicated to investing in early-stage biotechnology companies with the potential to improve global health. The firm focuses on identifying critical therapies developed by ambitious entrepreneurs and connecting them with a network of investors. Their mission underscores a commitment to deploying capital strategically to advance global health outcomes, aligning investments with impactful causes.

The firm specializes in the life sciences sector, including biotechnology, medtech, and pharmaceuticals. They typically invest in pre-seed and seed-stage companies, with investments starting above €3 million. LifeLink Ventures has a geographical focus on Spain, the United States, Brazil, Mexico, Germany, and the Netherlands. Their portfolio spans various industries within the life sciences, such as biotechnology, healthcare, medtech, pharmaceuticals, medical devices, diagnostics, regenerative medicine, genomics, immunology, oncology, neurology, cardiology, endocrinology, infectious diseases, and rare diseases.

LifeLink Ventures is headquartered in Barcelona, Spain, and operates with a team that brings together decades of experience at the intersection of biotech innovation and capital markets. Their active networks span the US, Europe, and Latin America, positioning them uniquely to bridge scientific opportunity with financial and strategic support. The firm's relationships with high-net-worth individuals, pharma executives, and cross-border investors allow them to unlock capital and partnerships that fuel scale. Their investment philosophy emphasizes long-term partnerships with founders, understanding their vision and DNA over time to foster excellence and success.